What Happened?
Portsmouth, NH-based MediSpend Appointed Jim Despelteau as Chief Technology Officer
About the Company
The first end-to-end compliance and business data analytics SaaS solutions technology provider for global pharmaceutical, biotech and medical device companies. Developed by a team of experienced attorneys and IT experts, the MediSpend Global Compliance platform is the market-leading, cost-effective and proven aggregate spend solution that improves global compliance for pharmaceutical, biotech and medical device companies. Designed specifically to help life sciences executives make better-informed business decisions while ensuring compliance for global transparency and health care laws. The MediSpend Global Compliance Platform is a modular suite of applications; Engagement Manager, Aggregate Spend and Insight. These three offerings are specifically designed to address global regulatory compliance laws across the life sciences industry. Engagement Manager organizes the entire HCP engagement process through the four crucial steps, identification, qualification, selection and monitoring. Aggregate Spend is a SaaS cloud-based platform and suite of applications designed specifically to address global transparency and aggregate spend reporting requirements for life sciences companies. Insight leverages compliance data to manage risk and communicate business value to key stakeholders. These analytics provide real-time compliance monitoring that reduces risk for the company.
About the Person
Jim Despelteau is Chief Technology Officer at MediSpend. Previously, Jim held various senior IT leadership roles in the industry.
Info Source
News
Short Profile